|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Resistant Solid Malignancies | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neoplasms | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Doxorubicin | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antibiotics, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Washington University School of Medicine | |||||